Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Arch Biopartners Inc
V.ARCH
Alternate Symbol(s):
ACHFF
Technology
Scientific & Technical Instruments
Arch Biopartners Inc. is a late-stage clinical trial company focused on preventing acute kidney injury. The Company is developing a platform of new drugs to prevent inflammation injury in the kidneys, lungs and liver via the dipeptidase-1 (DPEP1) pathway and are relevant for many common injuries and diseases where organ inflammation is an unmet problem. The Company’s lead drug candidate is...
LSALT Peptide. The Company is engaged in the clinical development of LSALT Peptide and other DPEP-1 targeting drug candidates for indications where inflammation of the lungs, liver and kidneys is an unmet problem. LSALT Peptide is in a second phase II trial, targeting the prevention and treatment of cardiac surgery-associated acute kidney injury (CS-AKI). The Company has additional technology platforms in its portfolio, which are AB569 and Borg. AB569 is an anti-infective candidate for treating or preventing antibiotic resistant bacterial infections, primarily as a topical treatment for wounds.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:ARCH)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(9)
•••
Riverfolk
X
View Profile
View Bullboard History
Post by
Riverfolk
on Nov 03, 2021 8:51am
Arch Biopartners - My Due Diligence
Here is the science published by a world renounced third party: Dipeptidase-1 ( Metablok) mice, with survival increasing from 0% to 83
...more
(5)
•••
TheBearInTheWoods
X
View Profile
View Bullboard History
Post by
TheBearInTheWoods
on Nov 03, 2021 8:36am
Largest Bid On Record (Premarket)
Someone is accumulating a huge position, make them pay for it! Diamond Hands !!
(5)
•••
TheBearInTheWoods
X
View Profile
View Bullboard History
Comment by
TheBearInTheWoods
on Nov 03, 2021 12:06am
RE:RE:Arch Biopartners - New Website
-The Metablok/Lsalt Peptide Animal trial videos are gone -The Trudeau Funding awareness is gone It's all about the science now
(93)
•••
SrPlata
X
View Profile
View Bullboard History
Comment by
SrPlata
on Nov 03, 2021 12:00am
RE:Arch Biopartners - New Website
I don't think they would be updating the website and giving a whole new look if the data was bad. Just Sayin
(9)
•••
Riverfolk
X
View Profile
View Bullboard History
Post by
Riverfolk
on Nov 02, 2021 11:22pm
Arch Biopartners - New Website
https://www.archbiopartners.com/
(2)
•••
2019champs
X
View Profile
View Bullboard History
Comment by
2019champs
on Nov 02, 2021 10:16pm
RE:$3.13
Haven't sold a single share and i got in under a $1 almost 2 years ago. Why would i sell this thing at $3? It's still way undervalued. No one still knows about this company. The real fireworks
...more
(93)
•••
SrPlata
X
View Profile
View Bullboard History
Comment by
SrPlata
on Nov 02, 2021 8:48pm
RE:$3.13
Hi Bear, I bot more last week avg price 2.18 USD for ACHFF. Champagne will be popped when we are over $10 USD on the way to my target price of $20 plus, see my post on Steps to $20 USD, to me this is
...more
(5)
•••
TheBearInTheWoods
X
View Profile
View Bullboard History
Post by
TheBearInTheWoods
on Nov 02, 2021 8:27pm
$3.13
Has everyone sold or something? I figured a more celebratory mood for us long!
(9)
•••
Riverfolk
X
View Profile
View Bullboard History
Post by
Riverfolk
on Nov 02, 2021 4:24pm
Extremely Undervalued in Comparison to peers
The recent realization by the market has made the Arch chart look incredible, but lets no forget that we are extremely undervalued compared to our peers. Current Market
...more
(9)
•••
Riverfolk
X
View Profile
View Bullboard History
Post by
Riverfolk
on Nov 02, 2021 4:23pm
New All Time High - Above 50 day average volume
House Positions for C:ARCH from 20211102 to 20211102 House Bought $Val Ave Sold $Val Ave Net $Net
...more
(5)
•••
TheBearInTheWoods
X
View Profile
View Bullboard History
Post by
TheBearInTheWoods
on Nov 02, 2021 8:56am
Largest bid on record (Premarket)
60k bid in at 2.86 premarket! That's the largest bid I have ever seen on this play, previously it was 50k bid back when the FDA approval took place
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Comment by
GoldenArm
on Nov 02, 2021 8:36am
RE:Todays House Positions
Thanks for the report. What it tells me is that this stock is not on the radar of any those that can move it. I'm sure they are watching and waiting but at some point they will jump in especially
...more
(9)
•••
Riverfolk
X
View Profile
View Bullboard History
Post by
Riverfolk
on Nov 01, 2021 4:53pm
Todays House Positions
House Positions for C:ARCH from 20211101 to 20211101 House Bought $Val Ave Sold $Val Ave Net $Net
...more
(5)
•••
TheBearInTheWoods
X
View Profile
View Bullboard History
Comment by
TheBearInTheWoods
on Oct 30, 2021 11:00pm
RE:Extremely Undervalued in Comparison to peers
BLU failed there phase 2 the first attempt and they are currently worth 4 times Arch!!!! Extremely undervalued indeed!
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
One Property, One Focus on Advancing this Gold Project in Ontario
Options Trading for Retiring: Key Strategies in Balancing Retirement Income